Ms. Susanna Uusmaa is a biomedical scientist with broad expertise in Medical Sciences and in International Business. Holding an MSBS degree, she is results-driven to integrate modern smart technologies into making substantive contributions to the biomedical sector.
Having conducted research in neuroscience and oncology and having proudly graduated from Tallinn University of Technology (TALTECH) and Tallinn University School of Natural Sciences and Health, Ms. Uusmaa takes an evidence-based approach to her professional objectives and also to her endeavors as a passionate healthy lifestyle entrepreneuse.
With a background in biomolecular and medical sciences, she has recently co-founded Quantum Brain Research Institute with the aim of supporting the development of neuroscientific research for neurocritical treatment applications through instructive programs in mental health assessment and management. She is also the Chief Science Officer and Co-Founding Partner of Nutrily™ | Health & Wellness Builders, a dietary supplements, nutritional products, and sportswear European corporation established in Tallinn, Estonia. Additionally, she is the CSO & Co-Founding Partner of RegenerAge®Elite Clinic.
In collaboration with the Luxembourg Institute of Health and Luxembourg Centre for Systems Biomedicine, she developed a complete standard operating procedure for differentiating and generating fully functional glial cells from induced pluripotent stem cells (iPSCs) in only 30 days.
Ms. Susanna Uusmaa is the Chairwoman of the WAMS National Council of Estonia, Member of the Academy Faculty, Fellow of the Academy, Member of the WAMS Education and Training Board (ETB), a Member of the WAMS Coronavirus Committee, and a Member of the WAMS Executive Council.
Moreover, she holds over 6 years of hard-working experience in business operations and relationship building in more than 5 countries around the globe, having created and nurtured mutually beneficial partnerships, enhanced workflow efficiency, and contributed to the growth of several initiatives with substantial savings.
Ms. Uusmaa’s biomedical undertakings have positioned her as an MSBS to be able to become an active contributor also to the longevity sector and put her expertise into helping people become their best version of themselves with properly validated and ethical practices.
Dr. Walter Bini, MD, PhD, is a distinguished Senior Consultant Neurosurgeon at Healthpoint Hospital in Abu Dhabi, UAE. With a remarkable career path that includes a close collaboration with the esteemed Prof. Dr. Madjid Samii in Hannover, Germany, Dr. Bini has established himself as an authority in the field of neurosurgery.
Dr. Bini’s expertise extends to various subfields within neurosurgery, encompassing general micro neurosurgery, the management of head trauma, neurooncology, stereotaxy and radiosurgery, as well as spinal surgery, including less invasive techniques and neuroradiology. His dedication and passion for these specialized areas have solidified his reputation as a leading authority in the field.
Notably, Dr. Bini has been serving as the Middle East Chairman of the International Society for the Advancement of Spine Surgery (ISLASS) since 2014, demonstrating his commitment to advancing spinal surgery practices in the region. Moreover, he actively contributes to the field as an active member and board member of various international societies, including the Skull Base Study Group, the German Neurosurgical Society (SAS), the American Association of Neurological Surgeons (AANS), and others.
In addition to his expertise in neurosurgery, Dr. Bini possesses impressive linguistic skills. He is fluent in English, German, Spanish, Italian, and has a working knowledge of French. These language abilities allow him to effectively communicate with patients from diverse backgrounds, fostering trust and understanding.
Dr. Bini’s contributions to the medical field extend beyond his clinical practice. Since 2017, he has served as the Lead Neurosurgeon at the Waldkrankenhaus for Special Surgeries in Leipzig, Germany, specifically focusing on trauma, sports-related injuries, and spine-related conditions. Furthermore, Dr. Bini holds an executive board member position and serves as the Dean of the Faculty of the World Academy of Medical Sciences (WAMS), reflecting his commitment to academic excellence and fostering future generations of medical professionals. Additionally, he holds a faculty position at the London Medical Education Academy in the United Kingdom, further showcasing his dedication to medical education and knowledge dissemination.
Dr. Walter Bini’s extensive experience, exceptional skills, and contributions to the field of neurosurgery have solidified his reputation as an eminent neurosurgeon. His remarkable achievements and multifaceted roles as a clinician, researcher, educator, and leader continue to shape the landscape of neurosurgical practice, making him a respected figure among colleagues and an invaluable asset to the medical community.
Adipose-derived Mesenchymal Stem Cells in the Treatment of Degenerative Spine Conditions: Protocol and personal experience with DDD
Lumbar degenerative disc disease (DDD) poses an ongoing challenge as far as treatment options and alternatives, especially when considering younger patients. Over 80% of the adult population presents with one or more episodes of ongoing-progressive low-back pain (LBP). The primary cause is associated with degeneration of the intervertebral disc and which is triggered by a decrease in the nucleus pulposus cell population, as evidenced in histological studies. Definitely, in the presence of a “black disc” without profusion and neurological compromise, microsurgery or even fusion surgery should not be contemplated. Numerous percutaneous techniques have been propagated as the proper way to treat this condition throughout the literature in the past years. They have been primarily focused on the treatment of the pain generated by the involved disc and the subsequent segmental insufficiency, without addressing the degeneration of the disc and for this have had limited success and remain as pain management tools. Some significant trials in the past (i.e. Chondrocyte transplantation trial) and the increasing recent research and achievements with more biological strategies as far as tissue regeneration has motivated the development of a new treatment concept initially applicable to the lumbar spine which will be presented and discussed.
Advancements have led to a significant improvement in the understanding of the cell environment and tissue transplantation at a molecular, cellular and immunobiological level. Adipose tissue has already become a central source of clinical and research work involving adipose tissue-derived progenitor cells. Endothelial and mesenchymal stem cells derived from adipose tissue are being considered and used in an array of clinical conditions and seem to have clear therapeutic benefits for many disease conditions including those affecting bone, cartilage and muscle. The use of an accessible source with abundant cells which have a high potential for regeneration clearly is superior in comparison to the chondrocyte option for the lumbar disc. Mesenchymal cells have a high self-renewal capacity and a potential for multi-lineage differentiation. For this, adipose tissue-derived MSCs (ADMSCs) are optimal candidates for tissue regeneration and can be obtained from the patient in a one-step procedure treatment.
Edward Cole is CEO of KATLAS Technology Limited, a leading Distributed Ledger Technology (DLT) firm in London. His journey began with a degree in Economics from the University of Leeds, laying the groundwork for his profound understanding of financial markets and economic trends.
Edward’s career has witnessed the transformation of financial markets from manual processes and paper-based systems to electronic trading and automated settlement. He navigated this evolution by negotiating licenses for new products with the London Stock Exchange, addressing the challenges of growing international markets and heightened regulatory scrutiny. During his tenure at Gerrard & National Ltd (1986-1993), Edward’s responsibilities spanned treasury cash management, stock operations, and settlements. An early adopter of Bloomberg, he recognized its value in market consensus for asset closing prices, facilitating informed risk management and boosting trading efficiency.
From here Edward joined the triple A-rated Union Bank Of Switzerland as a Director of Fixed Income Trading at UBS specializing in UK Inflation-Linked government bonds which later expanded into US & European as the markets developed.
In 2002, he accepted the role of Head of Global Inflation Sales at HSBC in London, to establish a centre of excellence, orchestrating the launch of the largest syndicated inflation issue at the time. As ambassador for this growing asset class, Edward introduced prominent global inflation managers to the organization, such as Pimco, Bridgewater, and BlueCrest.
Subsequently, Edward was invited to establish a new trading operation as the Head of Inflation at King & Shaxson Limited, an esteemed and longstanding organization in the City. Under his leadership, the company swiftly emerged as the UK market leader in inflation trading, achieving over 50% of the market turnover within two years, thanks to modern and reliable electronic matching and settlement systems.
At this time Edward co-founded Sciemus, now Occam Underwriters, serving as the Managing Director of Space Insurance. By utilising proprietary intelligence and risk modelling developed in collaboration with the MOD in Farnborough, satellite operators, such as Immarsat, were empowered to self-insure their portfolios with special purpose vehicles, delivering dramatic reductions in insurance premiums and changing the industry.
In 2019, driven by an entrepreneurial vision, Edward established KATLAS Technology Limited with a focus on enhancing data management in healthcare and supply chains. The initial product, MaiHealth, aimed to showcase responsible AI integration across the patient pathway, prioritizing personalized treatment while ensuring the utmost confidentiality of sensitive data. As the CEO, Edward Cole continues to lead KATLAS Technology, utilizing his extensive background in finance and technology to pioneer innovations in Distributed Ledger Technology, governance, and automated trading platforms. His journey reflects visionary leadership and a steadfast commitment to excellence in the dynamic intersection of finance and technology.
Prof. Dr. M. Mark Karindas, MD, is a respected medical professional with a remarkable career dedicated to advancing the field of medicine. With over two decades of service, he holds the esteemed position of President and Founder at WAMS, The World Academy of Medical Sciences. Additionally, he serves as the distinguished Editor-in-Chief of the prestigious Journal of Oncobiomarkers, Associate Editor of the esteemed American Journal of Biomedicine, and is a valued member of the Editorial Board for the Journal of Cancer Sciences.
As a highly accomplished research scientist specializing in Clinical and Molecular Oncology, Dr. Karindas has made significant contributions to the field. He is renowned for his groundbreaking theories, including the Multicellular Origin of Cancer and “Oncogenetic Evolution,” as well as the OCAT and ECE theories. His pioneering work extends to the development of the Karindas Grading System (KGS), a comprehensive and universal paradigm for tumor grading, and a novel approach to clinical management in oncology.
Dr. Karindas’ research interests encompass a broad spectrum of critical areas within oncology, including oncogenesis, metastasis, cancer stem cells, tumor cell biology, molecular oncopathology, cell signaling, signal transduction, extracellular matrix, and the origin and evolution of cancer. Currently, he is diligently engaged in the creation and establishment of a revolutionary medical algorithmic system that will revolutionize the practice of oncology and have far-reaching implications across various medical disciplines.
Dr. Karindas’ unwavering dedication to advancing medical knowledge and improving patient care has positioned him as a prominent figure in the medical community. His groundbreaking research, visionary theories, and commitment to developing innovative approaches underscore his invaluable contributions to the field of medicine.
The Karindas Grading System (KGS): Integrating Regenerative Medicine for a Comprehensive Understanding of Cancer Origins
In the field of oncohistopathology and oncobiopathology, grading systems play a crucial role in assessing tumor characteristics, guiding prognostic evaluations, and informing therapeutic decisions. However, the existing grading systems have limitations in interpretation, application, and uniformity. To address these challenges, we present the Karindas Grading System (KGS), a novel and comprehensive approach that integrates regenerative medicine concepts to revolutionize our understanding of cancer origins.
This presentation begins with an overview of the current grading systems used in oncohistopathology and oncobiopathology. These systems often rely on three-tier scales based on histologic characteristics, including parameters like mitotic activity and tumor necrosis. While practical, these systems have limited boundaries and lack the efficiency required for effective clinical case management and research studies.
We then introduce the development of the Karindas Grading System (KGS) in the context of regenerative medicine. The KGS aims to provide a more holistic assessment of tumor cells by examining their maturation, differentiation, and alterations, as well as evaluating their cellular activities and organization. By incorporating regenerative medicine concepts, the KGS offers a deeper understanding of phenotypic and genotypic descriptions in vivo, enabling precision diagnostics, prognostic evaluation, and tailored therapies.
The role of the KGS extends beyond individual tumor cells to assess tissue identities within the context of cancer progression. It offers insights into the dynamic interactions between cancer cells and their microenvironment, with implications for regenerative medicine research and the development of innovative therapy approaches.
In clinical practice, the KGS has significant applications. It can be integrated into tumor staging and prognostic evaluation, providing clinicians with a more comprehensive and informative assessment of patient cases. Additionally, the KGS enhances personalized treatment approaches, leveraging regenerative medicine techniques to optimize therapeutic decision-making for improved patient outcomes. Case examples showcase the practical application of the KGS, highlighting its potential in guiding clinical management.
Furthermore, the KGS unveils the obscure corners of oncogenesis, contributing to a better understanding of the underlying processes. It aids in identifying key factors and mechanisms involved in cancer development, paving the way for targeted interventions and regenerative medicine-based therapies.
Adriana De La Parra Solomon is a highly accomplished and esteemed Sports Nutrition consultant based in Vancouver, BC, Canada. With her wealth of knowledge and expertise, she has made significant contributions to the field of nutrition and has established herself as a leading authority in sports nutrition.
Adriana holds an impressive academic background, having completed an MSc in Human Nutrition from the renowned University of McGill in Montreal, Canada. She also obtained a Bachelor’s Degree in Nutrition and Food Science from the prestigious Universidad Iberoamericana in Mexico City. This combination of educational achievements has provided her with a strong foundation in understanding the intricate relationship between nutrition and human performance.
Currently, Adriana serves as a Food Service Supervisor at Lions Gate Hospital in Vancouver Coastal Health, BC, Canada, where she applies her expertise in nutrition to optimize the dietary needs of patients and promote their overall well-being. Furthermore, she holds the esteemed position of Sports Nutrition lecturer at the Instituto Universitario Vive Sano in São Paulo, Brazil, where she imparts her vast knowledge to aspiring nutrition professionals, helping them understand the importance of proper nutrition in sports and physical performance.
Throughout her career, Adriana has held various influential roles that have allowed her to shape the field of sports nutrition. She served as a health educator and nutritionist at Vitasave, a prominent natural health company in Vancouver, BC, Canada. Additionally, she was a Sports Nutrition lecturer at Universidad Intercontinental in Mexico City, where she shared her expertise with students, inspiring them to pursue excellence in the field of nutrition.
Adriana’s remarkable achievements extend beyond her teaching and clinical practice. She has played a pivotal role as the Chief Sports Nutrition Advisor in RegenerAge® Europe and Nutrily.eu, showcasing her ability to provide valuable insights and guidance in the development of sports nutrition programs and strategies. Furthermore, she has worked as a Sports Nutrition consultant for Olympic athletes at the National Sports Commission (CONADE/CNAR) in Mexico City, where she contributed to optimizing the performance and well-being of elite athletes. Adriana also worked as a sports scientist for the Formula 1 race, serving as the main point of contact in the build-up to the Grand Prix at the Sports Science Agency in Mexico City.
Adriana has dedicated herself to furthering her expertise in Sports Nutrition and has earned specialization recognition from the International Olympic Committee. She has served as a consultant in Sports Nutrition for GSSI Mexico for five years, demonstrating her commitment to staying at the forefront of advancements in the field. Moreover, she held the esteemed position of Continuing Education Coordinator at the Academic Board of the Mexican Federation of Sports Nutrition (FMND, A.C.), contributing to the ongoing professional development of sports nutrition practitioners in Mexico. Adriana’s passion for sports nutrition is also evident through her previous role as an assistant in nutrition at the High-Performance Centre (CAR) of the Mexican Football Federation.
Her dedication to knowledge sharing and education is further exemplified by her teaching experiences. Adriana served as a teacher of Sports Nutrition at the Technological University of Mexico (UNITEC), National Marine campus, and taught a module of the Sports Nutrition Diploma at Universidad Intercontinental (UIC), Insurgentes Campus. Her ability to effectively communicate complex concepts and inspire future nutrition professionals has been widely recognized and appreciated.
Additionally, Adriana is an anthropometrist ISAK Level 2, showcasing her expertise in body composition assessment techniques, which further enhances her ability to provide comprehensive and personalized nutrition guidance.
With her extensive experience, profound knowledge, and commitment to excellence, Adriana De La Parra Solomon continues to make a significant impact in the field of sports nutrition. Her participation in the medical conference promises to be enlightening and inspiring, as she shares her expertise and contributes to the ongoing advancement of sports nutrition practices worldwide.
Fueling Performance and Enhancing Recovery: The Synergy of Sports Nutrition and Regenerative Medicine
In the realm of sports medicine, the integration of sports nutrition and regenerative medicine has emerged as a compelling approach to optimize athlete performance, accelerate recovery, and promote overall well-being. This comprehensive presentation delves into the principles, practical applications, and potential advancements in these two disciplines, exploring their synergistic potential to reshape the landscape of sports medicine.
Drawing upon an evidence-based approach, the presentation delves into the intricate realm of sports nutrition, illuminating its pivotal role in optimizing athletic performance, supporting tissue repair, and modulating inflammation. With a focus on tailored dietary strategies, attendees will gain insights into the significance of macronutrient composition, timing of nutrient intake, and personalized hydration strategies in optimizing energy availability, muscle recovery, and enhancing overall athletic capacity.
Parallelly, the presentation ventures into the ever-evolving field of regenerative medicine, exploring the latest advancements and cutting-edge therapies. Attendees will gain a deeper understanding of the diverse types of stem cells, including embryonic, adult, and induced pluripotent stem cells (iPSCs), and their potential for tissue regeneration and repair. Furthermore, the role of regenerative therapies such as platelet-rich plasma (PRP) treatments, tissue engineering, and the use of biomaterials will be explored in the context of enhancing recovery and facilitating healing.
To emphasize the importance of a collaborative approach, the presentation highlights successful case studies that showcase the power of multidisciplinary teamwork between dietitians and medical professionals. Attendees will gain valuable insights into the seamless integration of personalized nutrition plans with regenerative therapies, underscoring the significance of coordinated interventions for comprehensive patient care and improved treatment outcomes.
The presentation also ventures into the realm of future trends and possibilities, exploring the potential impact of wearable devices for monitoring and tracking athletes’ physiological parameters, the integration of artificial intelligence and machine learning in personalized nutrition and regenerative medicine, as well as the incorporation of virtual reality in rehabilitation and performance optimization.
By providing attendees with a deepened understanding of the interplay between sports nutrition and regenerative medicine, this presentation equips practitioners with the knowledge and tools to develop individualized nutrition plans, implement innovative interventions, and optimize athlete performance, facilitate injury recovery, and promote long-term health. The potential for interdisciplinary collaboration and the exciting possibilities on the horizon make this presentation a must-attend for healthcare professionals and sports medicine enthusiasts alike.
Dr. Ioannis Stavrou is an esteemed Anesthesiologist-Pain Specialist, renowned for his extensive expertise in the field of medical practice. With a remarkable background in Anesthesia, Pain Management, Palliative Care, Anatomy, Emergency Medicine, Intensive Care, and Oncology, he has consistently displayed a commitment to providing exceptional care to his patients.
Dr. Stavrou’s educational journey forms the foundation of his distinguished career. He earned his Doctor of Medicine (M.D.) from the prestigious Athens Medical School, where he laid the groundwork for his future contributions to the medical community. Building upon this, he obtained a Doctor of Philosophy (Ph.D.) in Clinical Anatomy from the same esteemed institution, delving deep into the intricate complexities of human anatomy.
As an accomplished Anesthesia Specialist, Dr. Stavrou has honed his skills in administering anesthesia and managing pain, drawing from his comprehensive knowledge and experience. His fervent curiosity about the molecular basis of acute and chronic pain, along with his keen interest in the epidemiology of neuropathic pain, has propelled him to the forefront of pain management research and innovation.
In addition to his clinical endeavors, Dr. Stavrou has dedicated himself to the noble art of teaching. His extensive teaching experience spans across the Medical and Dental Schools of the University of Athens, where he has inspired and guided both undergraduate and postgraduate students. Dr. Stavrou’s contributions to academia are further evidenced by his role as a co-author of numerous medical manuals, specially designed for postgraduate students, ensuring the continuous development of aspiring medical professionals.
Notably, Dr. Stavrou has been recognized for his leadership and commitment to advancing medical science. He serves as the Chairman of the WAMS National Council of Greece, an esteemed position within The World Academy of Medical Sciences, affirming his dedication to fostering excellence and collaboration among medical professionals. Furthermore, his membership in the Disciplinary Committee of the Hellenic Society of Pain Management and Palliative Care from 2016 to 2019 attests to his strong commitment to maintaining the highest standards of medical practice and ethics.
Dr. Ioannis Stavrou’s unwavering passion for his profession, his remarkable educational achievements, and his extensive contributions to patient care, research, teaching, and professional organizations have established him as a prominent figure in the field of Anesthesiology and Pain Management. With his unwavering dedication to improving the lives of patients, he continues to shape the future of medical practice, earning the respect and admiration of colleagues and patients alike.
Dr. Mohammad Azfar, MS, FACS, FRCSEd, is an esteemed medical professional specializing in General and GI surgery. With an impressive background and extensive experience, Dr. Azfar’s contributions to the field have made a significant impact on patient care and surgical advancements.
Throughout his career, Dr. Azfar has been actively involved in the care of trauma patients, particularly those affected by high-velocity Motor Vehicle Accidents, as well as Surgical Critical Care. His expertise extends to various procedures, including Upper Gastrointestinal Endoscopy (EGD), Lower GI Endoscopy (Colonoscopy), PEG Placement, Reinsertion, Endoscopic Variceal Ligation (EVL), Capsule Endoscopy, Anorectal Manometry, and Advanced Wound Care and Management. He has also been involved in a bariatric surgery program, where he has gained proficiency in Intragastric Endoscopic Balloon Insertion and Dilatation of Strictures Post LRAYGB. While these achievements demonstrate his versatility, Dr. Azfar’s primary interests lie in minimally invasive surgery for anorectal disorders, utilizing techniques such as VAAFT, EPSiT, harmonic hemorrhoidectomy, and Laser application in the treatment of fistula, hemorrhoids, varicose veins, and pelvic floor disorders. Trauma and Surgical Intensive Care, as well as Surgical Nutrition, continue to be his areas of special interest.
Dr. Azfar’s dedication to advancing medical knowledge is evident through his 35 publications in national and international journals, covering a wide range of topics in General and GI surgery. Notably, he serves as the international editor of the Surgical Recall Series (Editions 3rd through 9th) by Lipincott Williams and Wilkins, Baltimore, USA, and is a valued member of several editorial boards for surgical publications.
Currently, Dr. Azfar holds the position of Consultant General Surgeon at Burjeel Holdings, LLH Hospital Musaffah Abu Dhabi, UAE. He has previously served as a Consultant Surgeon at Somerian Health and the Advanced Center for Daycare Surgery. His impressive achievements include being the former President of the ACS UAE Chapter of the American College of Surgeons, former Vice President of the ACS UAE Chapter of the American College of Surgeons, former Consultant Surgeon, Head of General Surgery, and Acting Chief of Service at Al Rahba Hospital (Managed by Johns Hopkins Medical International).
Dr. Azfar’s educational journey has equipped him with the knowledge and skills necessary for his outstanding career. He holds a Fellowship from The Royal College of Surgeons, Edinburgh, UK (FRCSEd), a Fellowship in General Surgery from the American College of Surgeons (FACS), and a Master in Surgery (MS) from JN Medical College, India. He also completed his MBBS and MS (Surgery) at JN Medical College, India.
Regenerative Medicine in Gastrointestinal Disorders: Unlocking the Potential for Tissue Restoration and Improved Patient Outcomes
Gastrointestinal disorders pose significant challenges in the realm of medical management, necessitating innovative approaches to address the complex pathophysiology and associated impact on patients’ quality of life. Regenerative medicine has emerged as a transformative field offering promising therapeutic strategies for gastrointestinal disorders. This keynote presentation provides a comprehensive overview of the intersection between gastrointestinal medicine and regenerative medicine, delving into the fundamental principles, potential applications, and translational challenges that lie ahead.
The presentation begins with an introduction, setting the stage for an exploration of the importance of regenerative medicine in gastrointestinal disorders. The current state of gastrointestinal medicine is then elucidated, highlighting the prevailing treatment approaches and their limitations. Building upon this foundation, the subsequent sections delve into understanding gastrointestinal disorders, encompassing an overview of common conditions, their pathophysiology, and the profound impact they exert on patients’ quality of life. Notably, the challenges faced by current treatment approaches are examined, underscoring the imperative for novel therapeutic modalities.
The heart of the presentation lies in the comprehensive exploration of regenerative medicine in gastrointestinal disorders. The fundamentals of regenerative medicine are elucidated, focusing on the key benefits and potential applications in the context of gastrointestinal complications. The underlying principles and techniques involved in regenerative therapies are detailed, shedding light on tissue engineering, stem cell biology, gene editing, and biomaterial sciences.
Furthermore, the presentation delves into in-depth therapeutic approaches within the realm of regenerative medicine for gastrointestinal complications. Specific strategies, such as tissue-specific organoids, organ-on-a-chip models, and bioprinting technologies, are explored as means to advance our understanding of gastrointestinal physiology and pathology. Moreover, the integration of regenerative therapies with conventional treatment modalities is examined, emphasizing the potential for synergistic effects and improved patient outcomes.
As the field progresses, the presentation addresses the translational challenges and future directions of regenerative therapies in gastrointestinal medicine. Safety and efficacy considerations, standardization and quality control measures, delivery strategies, integration with existing therapies, and cost-effectiveness and accessibility concerns are explored. Promising avenues for future research, including the utilization of artificial intelligence and machine learning, are highlighted, underscoring the need for multidisciplinary collaboration and innovative thinking to propel the field forward.
This keynote presentation serves as a comprehensive guide to the multifaceted landscape of regenerative medicine in gastrointestinal disorders. It underscores the potential of regenerative therapies to revolutionize patient care by not only mitigating symptoms but also by restoring tissue function and ultimately improving the quality of life for those afflicted by gastrointestinal conditions. By addressing the translational challenges and charting future directions, we pave the way for a regenerative future that holds immense promise for patients worldwide.
Aivar Uus is a highly skilled biomedical laboratory scientist, primarily experienced in hospital laboratory diagnostics. Beyond that, his theoretic focus is on the areas of human energetics, stem cells, and immunology, while further practical applications are teaching, presentations, scientific paper composition, and freelance work.
His laboratory competence stems from Tartu Healthcare College, where he graduated in 2013 to become a Bachelor of Applied Science (BASc) as a biomedical laboratory scientist. His bachelor’s thesis, “Optimizing the Leishman-Giemsa Stain for Practical Lessons in Tartu Healthcare College,” highlighted a systemic approach to enhancing laboratory techniques. This degree qualifies him to work in a hospital setting, which has been his day job in the North-Estonian Medical Centre from graduation to this day, with a hiatus between 2015-16. His tasks have mostly encompassed operating numerous analyzers, conducting quality control, and validating patient results. Aivar’s exceptional technical skills and his dedication to maintaining high standards of accuracy and precision, as well as his ability to independently solve various problems as they arise, have been crucial to ensuring in-time reliable diagnostic outcomes.
Aivar’s educational background showcases a Master of Science (MS) degree in Molecular Biochemistry and Ecology from Tallinn University, graduated in 2016. His Master’s thesis, titled “Developmental and Age-Related Changes of Myocardial Phosphotransfer Network Profiles,” helped build a systems-biology-inspired view of human energetics, unifying the research fields of biochemistry, energy fluxes in living cells and in whole-body sciences, such as stress and sports physiology.
His proficiency in scientific communication and his ability to convey complex concepts with clarity has enabled him to transfer scientific content into diverse forms. He has demonstrated his versatility as a freelance scientific papers writer and editor. These manuscripts have delved into various topics, giving a wider view of various scientific fields. Since 2016, he has been associated with SciLanguage – Vabakutselised, where he provides translation, editing, proofreading, and summarizing services. He has also regularly given presentations on the topics of stem cells or energetics, at the Medical Centre and at meetings of the Association of Estonian Biomedical Laboratory Scientists.
The most demanding of his projects have extended to teaching graduate and post-graduate education. Since 2016, he has been actively engaged in academia as a Contract Lecturer at Tartu Healthcare College, where his expertise in certain fields has allowed him to develop a comprehensive and engaging curriculum. Most notably, he has de novo composed two distinct 2 EAP (European Credit Transfer and Accumulation System) courses. First, his Master’s thesis gave foundation to composing and teaching to 3rd-grade students the unique course of “Introductory Bioenergetics”, the contents of which have kept expanding each year. The other is “Stem Cells in Clinical Practice” for 3rd and 4th-year students. Alongside theory, his ability to transfer practical laboratory skills has been employed by having him teach actual hospital work to new colleagues, as well as students obtaining study practice or taking the course “Clinical Chemistry”.
Aivar’s contact with stem cells began at the end of Healthcare College in 2012, during specialization study practice at the North Estonian Medical Centre’s immunology department, where he also had the chance to work with autologous hematopoietic stem cells. After graduation, he first worked at a blood transfusion centre from 2013 to 2015, performing immunohematological quality-control tests and reference analysis for complex donor matching. This is complemented by a 2015 Master’s level study practice in organ and allogenic HSC donor matching.
With the goal to promote and connect the locally underdeveloped field of regenerative medicine, as well as to build up and ascertain his personal competence, Aivar composed his second de novo course, “Stem Cells in Clinical Practice”, which was first launched in 2020. In 2022, he trained as a Production Specialist at Cellin Technologies, giving him professional hands-on competence for working in clean room conditions to produce cells for clinical consumption.
Aivar has obtained extensive experience in medical and biomedical laboratory settings, has contributed to the field of biomedical science with an unwavering commitment to precision and academic excellence, and has become known as a smart and capable figure in the medical community. Such relationships with biomedical theory, laboratory practice, the clinical side of medicine, and active agents in Estonia have made him an all-rounder regarding stem cells. With his passion for innovative research and the regenerative field, he is well suited for a central position in it.